Hepatic Cell News Volume 8.07 | Feb 23 2024

    0
    8








    2024-02-23 | HCN 8.07


    Hepatic Cell News by STEMCELL Technologies
    Vol. 8.07 – 23 February, 2024
    TOP STORY

    A Phase III Trial of Seladelpar in Primary Biliary Cholangitis

    In this Phase III, 12-month, double-blind, placebo-controlled trial, researchers randomly assigned patients who had had an inadequate response to or who had a history of unacceptable side effects with ursodeoxycholic acid to receive oral seladelpar at a dose of 10mg daily or placebo.
    [New England Journal Of Medicine]

    Abstract
    PUBLICATIONSRanked by the impact factor of the journal

    ASK1/p38 Axis Inhibition Blocks the Release of Mitochondrial “Danger Signals” From Hepatocytes and Suppresses Progression to Cirrhosis and Liver Cancer

    Short- and long-term ASK1 inhibition using small molecule GS-444217 was tested in thioacetamide-induced and BALB/c.Mdr2-/- murine models of cirrhosis and HCC, and in vitro using primary hepatocyte cell death assays.
    [Hepatology]

    Abstract

    Enhanced SLC35B2/SAV1 Sulfation Axis Promotes Tumor Growth through Inhibiting Hippo Signaling in Hepatocellular Carcinoma

    By mass spectrometry and bioinformatics analysis, investigators identified SAV1 as a novel substrate of PTS in HCC. Oxidative stress upregulates the transcription of SLC35B2, a Golgi-resident transporter of sulfate donor 3’-phosphoadenosine 5’-phosphosulfate, leading to increased sulfation of SAV1.
    [Hepatology]

    AbstractGraphical Abstract

    KIF18A Inactivates Hepatic Stellate Cells and Alleviates Liver Fibrosis through the TTC3/Akt/mTOR Pathway

    Researchers observed a decrease in the expression of KIF18A in fibrotic liver tissues compared to healthy liver tissues, which exhibited a negative correlation with the activation of hepatic stellate cells.
    [Cellular And Molecular Life Sciences]

    Full Article

    Kupffer Cells Abrogate Homing and Repopulation of Allogeneic Hepatic Progenitors in Injured Liver Site

    The authors induced an acute inflammatory regenerative niche on the surface of the liver by the application of cryo-injury to systematically evaluate the innate immune response against transplanted allogeneic hepatic progenitors in a sustained micro-inflammatory environment.
    [Stem Cell Research & Therapy]

    Full Article

    Chronic Stress Alters Hepatic Metabolism and Thermodynamic Respiratory Efficiency Affecting Epigenetics in C57Bl6 Mice

    In male C57BL/6 mice, chronic variable stress reduced energy expenditure (EE) and body mass despite increased energy intake versus controls. This coincided with decreased glucose metabolism and increased lipid ß-oxidation, correlating with EE.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Cryptogenic Non-Cirrhotic HCC: Clinical, Prognostic and Immunologic Aspects of an Emerging HCC Etiology

    Cryptogenic non-cirrhotic HCC exhibited similarities with non-cirrhotic NAFLD HCC, but displayed advanced tumor stages, lower surgical rates, and a more frequent presence of symptoms, which substantiated in poor survival rates.
    [Scientific Reports]

    Full Article

    TET1 Inhibits Liver Fibrosis by Blocking Hepatic Stellate Cell Activation

    Scientists investigated the involvement of hydroxymethylase ten–eleven translocation 1 (TET1) in HSC activation and liver fibrosis. It was revealed that TET1 levels were downregulated in the livers in mouse models of liver fibrosis and patients with cirrhosis.
    [Journal Of Gastroenterology And Hepatology]

    Abstract

    A Comprehensive Survey of Warfarin-Induced Hepatic Toxicity Using Histopathological, Biomarker, and Molecular Evaluation

    Wild female and male rats were administrated orally with warfarin for 18 days at 9, 18, 27.5, and 55 mg/kg, respectively. Hepatoxicity was determined by assessing, LD50, leukocyte counts, immunochemistry, histopathology, serum proteins, Western blotting, especially of markers of liver injury.
    [Heliyon]

    Full ArticleGraphical Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    Protective Effects of Hepatic Diseases by Bioactive Phytochemicals in Fusarium oxysporum – A Review

    Scientists highlight on the bright side of Fusarium oxysporum and introduce the functional activities of its chemical compounds for treating its target diseases.
    [Heliyon]

    Full Article
    INDUSTRY AND POLICY NEWS

    NorthSea Therapeutics Initiates Phase IIA Trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD)

    NorthSea Therapeutics B.V. announced the dosing of the first patient in its Phase IIa clinical trial of Orziloben in IFALD, an orphan liver disease affecting individuals on prolonged intravenous nutrition.
    [NorthSea Therapeutics B.V.]

    Press Release

    Kashmir University Researcher Bags Chandrasekhar Memorial Award 2024

    Arjamand Mushtaq, a research scholar from the Centre for Interdisciplinary Research and Innovations, Kashmir University has been awarded the prestigious Chandrasekhar Memorial Award, 2024 for her contributions to Biomedical Sciences.
    [Brighter Kashmir]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2024

    April 7 – 10, 2024
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Clinical Research – Fellowship Hepatology

    Leeds Teaching Hospital – Leeds, England, United Kingdomn

    Senior Research Lab Manager – Liver Disease

    Virginia Commonwealth University – Richmond, Virginia, United States

    Postdoctoral Scientist – Liver Cancer Immunology

    Foundation for Liver Research – London, England, United Kingdom

    Senior Research Nurse – Liver Clinical Trials

    King’s College Hospital – London, England, United Kingdom

    Research Fellow – Achieving Functional Cure of Chronic Hepatitis B

    National University of Singapore – Singapore, Singapore

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2